ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,394Medicare Part D Prescriptions Filled, Including Refills

Rank: 66 out of 337

$532K Total Retail Price of All Prescriptions

Rank: 61 out of 337

425 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 425 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

9% of this provider’s 425 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 9,268 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
SIMVASTATIN 568 489 1 1
LEVOTHYROXINE SODIUM 331 254 2 5
LISINOPRIL 330 289 3 2
FUROSEMIDE 296 260 4 8
OMEPRAZOLE 295 294 5 4
METOPROLOL TARTRATE 273 239 6 6
TRAZODONE HCL 257 246 7 16
AMLODIPINE BESYLATE 246 236 8 3
ATORVASTATIN CALCIUM 233 220 9 7
ATENOLOL 194 189 10 10
CITALOPRAM HBR 191 166 11 17
DIOVAN 168 163 12 26
METFORMIN HCL 162 151 13 12
CRESTOR 158 145 14 29
HYDROCHLOROTHIAZIDE 155 147 15 9
SERTRALINE HCL 151 131 16 18
HYDROCODONE-ACETAMINOPHEN 141 116 S3 17 13
DONEPEZIL HCL 132 132 18 22
TAMSULOSIN HCL 124 121 19 25
PRAVASTATIN SODIUM 114 106 20 14
METOPROLOL SUCCINATE 113 113 21 21
ALENDRONATE SODIUM 112 112 22 19
BISOPROLOL FUMARATE 100 81 23 67
GABAPENTIN 97 95 24 20
GLIPIZIDE 96 81 25 45
QUETIAPINE FUMARATE 93 93 26 61
ZOLPIDEM TARTRATE 91 71 27 23
WARFARIN SODIUM 91 88 27 11
NAMENDA 91 91 27 35
ADVAIR DISKUS 88 60 30 44
FLUOXETINE HCL 87 70 31 57
PREDNISONE 86 77 32 40
RAMIPRIL 80 80 33 80
TRIAMTERENE-HCTZ 76 76 34 39
LOSARTAN POTASSIUM 73 73 35 15
VENLAFAXINE HCL ER 71 69 36 86
POTASSIUM CHLORIDE 69 65 37 62
ENALAPRIL MALEATE 68 54 38 37
ALLOPURINOL 66 63 39 28
FLUTICASONE PROPIONATE 66 59 39 34
PROAIR HFA 66 43 39 38
ZETIA 64 64 42 89
OXYCODONE-ACETAMINOPHEN 64 34 S2 42 84
NEXIUM 64 42 42 56
SYNTHROID 60 58 45 41
DILTIAZEM 24HR ER 59 59 46 76
VERAPAMIL ER 57 45 47 77
DIGOXIN 57 57 47 58
MIRTAZAPINE 55 55 49 27
FLOVENT HFA 54 46 50 155
TRAMADOL HCL 54 36 50 32
OXYBUTYNIN CHLORIDE 51 26 52 143
AZITHROMYCIN 50 44 53 51
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 1, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.